Former Executive Vice President, Chief Commercial Officer · ACADIA PHARMACEUTICALS INC (ACAD)

Michael Yang

A named executive officer of ACADIA PHARMACEUTICALS in every fiscal year CompBrief holds from FY2017 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$2,620,679

Salary $516,805Stock awards $932,316

FY2019: $2,943,821

3rd of 5 named executive officers at Acadia Pharmaceuticals by FY2020 total.

5 named officers on file for ACADIA PHARMACEUTICALS, FY2020

Michael Yang’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 9 equity grants, each cited to its filing
  • ACAD’s disclosed peer group of 23 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ACADIA PHARMACEUTICALS’s whole pay program stands against its peers

  • ACADIA PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ACAD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2021 (DEF 14A).

Free

Get Michael Yang’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Michael Yang compensation by year

ACADIA PHARMACEUTICALS Summary Compensation Table · all 4 fiscal years held
In US dollars, as ACADIA PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020
Salary$361,731$485,250$500,701$516,805
Bonus$0$0$0—
Stock awards$0$212,800$1,291,323$932,316
Option awards$11,460,367$2,077,607$842,087$935,316
Non-equity incentive$197,822$237,773$287,328$210,921
Pension and deferred compensation—$0$0—
All other$84,028$169,480$22,383$25,321
Total$12,103,948$3,182,910$2,943,821$2,620,679

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ACADIA PHARMACEUTICALS INC DEF 14A filed April 30, 2021, accession 0001564590-21-022589, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ACADIA PHARMACEUTICALS INC filed document, accession 0001564590-21-022589. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2021.

$12.1M
$3.2M
$2.9M
$2.6M
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
PSU38,213$2,042,856—
PSU16,827$899,571—
RSU12,621$674,719—
RSU10,889$582,126—
PSU10,889$582,126—
RSU5,000$267,300—
Option31,250—$35.80
Option20,000—$19.98
Option20,000—$19.98
Option20,000—$21.28
Option34,442—$25.12
Option39,516—$42.81

Per the Outstanding Equity Awards at Fiscal Year-End table in ACADIA PHARMACEUTICALS INC's FY2020 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 15 award rows shown.

ACADIA PHARMACEUTICALS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Stephen DavisChief Executive Officer$7,763,187
Srdjan StankovicFormer President$4,856,415
Michael Yang · this pageFormer Executive Vice President, Chief Commercial Officer$2,620,679
Elena RidloffFormer Executive Vice President, Chief Financial Officer$2,514,170
Austin KimExecutive Vice President, General Counsel, and Secretary$1,747,288

The full ACADIA PHARMACEUTICALS compensation record

free company brief

This page is one person within ACADIA PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ACADIA PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Yang's compensation dossier · One-time report. No refunds.